Enasidenib in mutant IDH2 relapsed or refractory acute myeloid leukemiaEytan M. Stein, Martin S. Tallman, Ross L. Levine et al.|Blood|2017Cited by 1.5k
CUG-binding protein 1 regulates HSC activation and liver fibrogenesisXingxin Wu, Qiang Xu|Nature Communications|2016Cited by 86
The effect of hydroxy safflower yellow A on coronary heart disease through Bcl‑2/Bax and PPAR‑γDayan Zhou, Qiang Xu|Experimental and Therapeutic Medicine|2017Cited by 28
Deciphering the pathogenic role of a variant with uncertain significance for short QT and Brugada syndromes using gene‐edited human‐induced pluripotent stem cell‐derived cardiomyocytes and preclinical drug screeningIbrahim El‐Battrawy, Xiaobo Zhou, Huan Lan et al.|Clinical and Translational Medicine|2021Cited by 22